CACNA1C (Ca v1.2) in the pathophysiology of psychiatric disease

Progress in Neurobiology

Volumn 99, Issue 1, 2012, Pages 1-14

  Bhat, Shambhu ^a   Dao, David T ^a   Terrillion, Chantelle E ^b   Arad, Michal ^a   Smith, Robert J ^a   Soldatov, Nikolai M ^c   Gould, Todd D ^a,b  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF MARYLAND   (United States)

^c Humgenex Inc   (United States)

Author keywords

Bipolar disorder; CACNA1C; Calcium channel; Depression; Genome wide association study; Psychiatric genetics; Schizophrenia

Indexed keywords

BENZOTHIAZEPINE DERIVATIVE; CALCIUM CHANNEL BLOCKING AGENT; CALCIUM CHANNEL CAV 1.2; CALCIUM CHANNEL L TYPE; DIHYDROPYRIDINE DERIVATIVE; NICARDIPINE; NIMODIPINE; PHENYLALKYLAMINE; PLACEBO; SEROTONIN UPTAKE INHIBITOR; UNCLASSIFIED DRUG; VERAPAMIL; VOLTAGE GATED CALCIUM CHANNEL; CACNA1C PROTEIN, HUMAN;

ANGINA PECTORIS; BEHAVIOR; BINDING AFFINITY; BIPOLAR DISORDER; BRAIN FUNCTION; BRAIN REGION; CACNA1C GENE; CALCIUM ANTAGONISM; CLINICAL FEATURE; DRUG PENETRATION; DRUG POTENTIATION; GENE; GENE FUNCTION; GENETIC VARIABILITY; GENETICS; HEART ARRHYTHMIA; HUMAN; HYPERTENSION; MAJOR DEPRESSION; MENTAL DISEASE; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REVIEW; SCHIZOPHRENIA;

CALCIUM CHANNELS, L-TYPE; GENETIC VARIATION; HUMANS; MENTAL DISORDERS;

EID: 84866551127     PISSN: 03010082     EISSN: 18735118     Source Type: Journal    
DOI: 10.1016/j.pneurobio.2012.06.001     Document Type: Review

References (176)

1. 2+ channel: perspectives for new pharmacological targets. Journal of Pharmacology and Experimental Therapeutics 2002, 300:724-728.
2. v1.2 L-type calcium channels via selected β subunits to enhance regulatory phosphorylation. Journal of Neurochemistry 2010, 112:150-161.
3. Bader P.L., Faizi M., Kim L.H., Owen S.F., Tadross M.R., Alfa R.W., Bett G.C., Tsien R.W., Rasmusson R.L., Shamloo M. Mouse model of Timothy syndrome recapitulates triad of autistic traits. Proceedings of the National Academy of Sciences USA 2011, 108:15432-15437.
4. Barad M. Later developments: molecular keys to age-related memory impairment. Alzheimer Disease & Associated Disorders 2003, 17:168-176.
5. v1.2 L-type calcium channels. Proceedings of the National Academy of Sciences USA 2008, 105:2157-2162.
6. Bauer E.P., Schafe G.E., LeDoux J.E. NMDA receptors and L-type voltage-gated calcium channels contribute to long-term potentiation and different components of fear memory formation in the lateral amygdala. Journal of Neuroscience 2002, 22:5239-5249.
7. Berrettini W. Evidence for shared susceptibility in bipolar disorder and schizophrenia. American Journal of Medical Genetics. Part C, Seminars in Medical Genetics 2003, 123C:59-64.
8. Biala G. Calcium channel antagonists suppress nicotine-induced place preference and locomotor sensitization in rodents. Polish Journal of Pharmacology 2003, 55:327-335.
9. Biala G., Kruk M. Amphetamine-induced anxiety-related behavior in animal models. Pharmacological Reports 2007, 59:636-644.
10. Biala G., Weglinska B. Calcium channel antagonists attenuate cross-sensitization to the rewarding and/or locomotor effects of nicotine, morphine and MK-801. Journal of Pharmacy and Pharmacology 2004, 56:1021-1028.
11. Bigos K.L., Mattay V.S., Callicott J.H., Straub R.E., Vakkalanka R., Kolachana B., Hyde T.M., Lipska B.K., Kleinman J.E., Weinberger D.R. Genetic variation in CACNA1C affects brain circuitries related to mental illness. Archives of General Psychiatry 2010, 67:939-945.
12. 2+- and stimulus duration-dependent switch for hippocampal gene expression. Cell 1996, 87:1203-1214.
13. Brillantes A.M.B., Bezprozvannaya S., Marks A.R. Developmental and tissue-specific regulation of rabbit skeletal and cardiac muscle calcium channels involved in excitation-contraction coupling. Circulation Research 1994, 75:503-510.
14. Burton P.R., Clayton D.G., Cardon L.R., Craddock N., Deloukas P., Duncanson A., Kwiatkowski D.P., McCarthy M.I., Ouwehand W.H., Samani N.J., Todd J.A., Donnelly P., Barrett J.C., Burton P.R., Davison D., Donnelly P., Easton D., Evans D., Leung H.T., Marchini J.L., Morris A.P., Spencer C.C., Tobin M.D., Cardon L.R., Clayton D.G., Attwood A.P., Boorman J.P., Cant B., Everson U., Hussey J.M., Jolley J.D., Knight A.S., Koch K., Meech E., Nutland S., Prowse C.V., Stevens H.E., Taylor N.C., Walters G.R., Walker N.M., Watkins N.A., Winzer T., Todd J.A., Ouwehand W.H., Jones R.W., McArdle W.L., Ring S.M., Strachan D.P., Pembrey M., Breen G., St Clair D., Caesar S., Gordon-Smith K., Jones L., Fraser C., Green E.K., Grozeva D., Hamshere M.L., Holmans P.A., Jones I.R., Kirov G., Moskvina V., Nikolov I., O'Donovan M.C., Owen M.J., Craddock N., Collier D.A., Elkin A., Farmer A., Williamson R., McGuffin P., Young A.H., Ferrier I.N., Ball S.G., Balmforth A.J., Barrett J.H., Bishop D.T., Iles M.M., Maqbool A., Yuldasheva N., Hall A.S., Braund P.S., Burton P.R., Dixon R.J., Mangino M., Suzanne S., Tobin M.D., Thompson J.R., Samani N.J., Bredin F., Tremelling M., Parkes M., Drummond H., Lees C.W., Nimmo E.R., Satsangi J., Fisher S.A., Forbes A., Lewis C.M., Onnie C.M., Prescott N.J., Sanderson J., Mathew C.G., Barbour J., Mohiuddin M.K., Todhunter C.E., Mansfield J.C., Ahmad T., Cummings F.R., Jewell D.P., Webster J., Brown M.J., Clayton D.G., Lathrop G.M., Connell J., Dominczak A., Samani N.J., Marcano C.A., Burke B., Dobson R., Gungadoo J., Lee K.L., Munroe P.B., Newhouse S.J., Onipinla A., Wallace C., Xue M., Caulfield M., Farrall M., Barton A., Bruce I.N., Donovan H., Eyre S., Gilbert P.D., Hider S.L., Hinks A.M., John S.L., Potter C., Silman A.J., Symmmons D.P., Thomson W., Worthington J., Clayton D.G., Dunger D.B., Nutland S., Stevens H.E., Walker N.M., Widmer B., Todd J.A., Frayling T.A., Freathy R.M., Lango H., Perry J.R., Shields B.M., Weedon M.N., Hattersley A.T., Hitman G.A., Walker M., Elliott K.S., Groves C.J., Lindgren C.M., Rayner N.W., Timpson N.J., Zeggini E., McCarthy M.I., Newport M., Sirugo G., Lyons E., Vanberg F., Hill A.V., Bradbury L.A., Farrar C., Pointon J.J., Wordsworth P., Brown M.A., Franklyn J.A., Heward J.M., Simmonds M.J., Gough S.C., Seal S., Stratton M.R., Rahman N., Ban M., Goris A., Sawcer S.J., Compston A., Conway D., Jallow M., Newport M., Sirugo G., Rockett K.A., Kwiatowski D.P., Bumpstead S.J., Chaney A., Downes K., Ghori M.J., Gwilliam R., Hunt S.E., Inouye M., Keniry A., King E., McGinnis R., Potter S., Ravindrarajah R., Whittaker P., Widden C., Withers D., Deloukas P., Leung H.T., Nutland S., Stevens H.E., Walker N.M., Todd J.A., Easton D., Clayton D.G., Burton P.R., Tobin M.D., Barrett J.C., Evans D., Morris A.P., Cardon L.R., Cardin N.J., Davison D., Ferreira T., Pereira-Gale J., Hallgrimsdottir I.B., Howie B.N., Marchini J.L., Spencer C.C., Su Z., Teo Y.Y., Vukcevic D., Donnelly P., Bentley D., Brown M.A., Gordon L.R., Caulfield M., Clayton D.G., Compston A., Craddock N., Deloukas P., Donnelly P., Farrall M., Gough S.C., Hall A.S., Hattersley A.T., Hill A.V., Kwiatkowski D.P., Mathew C., McCarthy M.I., Ouwehand W.H., Parkes M., Pembrey M., Rahman N., Samani N.J., Stratton M.R., Todd J.A., Worthington J. Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls. Nature 2007, 447:661-678.
15. 2+ channel isoforms in the extinction of conditioned fear. Learning & Memory 2008, 15:378-386.
16. Cain C.K., Blouin A.M., Barad M. L-type voltage-gated calcium channels are required for extinction, but not for acquisition or expression, of conditional fear in mice. Journal of Neuroscience 2002, 22:9113-9121.
17. Calcagnetti D.J., Schechter M.D. Attenuation of drinking sweetened water following calcium channel blockade. Brain Research Bulletin 1992, 28:967-973.
18. Cannon T.D., Kaprio J., Lonnqvist J., Huttunen M., Koskenvuo M. The genetic epidemiology of schizophrenia in a Finnish twin cohort. A population-based modeling study. Archives of General Psychiatry 1998, 55:67-74.
19. Cardno A.G., Gottesman I.I. Twin studies of schizophrenia: from bow-and-arrow concordances to star wars Mx and functional genomics. American Journal of Medical Genetics 2000, 97:12-17.
20. Casamassima F., Hay A.C., Benedetti A., Lattanzi L., Cassano G.B., Perlis R.H. L-type calcium channels and psychiatric disorders: a brief review. American Journal of Medical Genetics Part B: Neuropsychiatric Genetics 2010, 153B:1373-1390.
21. Casamassima F., Huang J., Fava M., Sachs G.S., Smoller J.W., Cassano G.B., Lattanzi L., Fagerness J., Stange J.P., Perlis R.H. Phenotypic effects of a bipolar liability gene among individuals with major depressive disorder. American Journal of Medical Genetics Part B: Neuropsychiatric Genetics 2010, 153B:303-309.
22. Catterall W.A. Voltage-gated calcium channels. Cold Spring Harbor Perspectives in Biology 2011, 3:1-23.
23. Chartoff E.H., Pliakas A.M., Carlezon W.A. Microinjection of the L-type calcium channel antagonist diltiazem into the ventral nucleus accumbens shell facilitates cocaine-induced conditioned place preferences. Biological Psychiatry 2006, 59:1236-1239.
24. Chubb J.E., Bradshaw N.J., Soares D.C., Porteous D.J., Millar J.K. The DISC locus in psychiatric illness. Molecular Psychiatry 2008, 13:36-64.
25. Cohen C., Perrault G., Sanger D.J. Assessment of the antidepressant-like effects of L-type voltage-dependent channel modulators. Behavioural Pharmacology 1997, 8:629-638.
26. Cuthbert B.N., Insel T.R. Toward new approaches to psychotic disorders: the NIMH Research Domain Criteria project. Schizophrenia Bulletin 2010, 36:1061-1062.
27. Czyrak A., Mogilnicka E., Maj J. Dihydropyridine calcium channel antagonists as antidepressant drugs in mice and rats. Neuropharmacology 1989, 28:229-233.
28. Czyrak A., Mogilnicka E., Siwanowicz J., Maj J. Some behavioral effects of repeated administration of calcium channel antagonists. Pharmacology Biochemistry & Behavior 1990, 35:557-560.
29. v1.2. Biochemical and Biophysical Research Communications 2002, 296:429-433.
30. Dao D.T., Mahon P.B., Cai X., Kovacsics C.E., Blackwell R.A., Arad M., Shi J., Zandi P.P., O'Donnell P., Knowles J.A., Weissman M.M., Coryell W., Scheftner W.A., Lawson W.B., Levinson D.F., Thompson S.M., Potash J.B., Gould T.D. Mood disorder susceptibility gene CACNA1C modifies mood-related behaviors in mice and interacts with sex to influence behavior in mice and diagnosis in humans. Biological Psychiatry 2010, 68:801-810.
31. v1.2 during aging. Proceedings of the National Academy of Sciences USA 2003, 100:16018-16023.
32. Deisseroth K., Heist E.K., Tsien R.W. Translocation of calmodulin to the nucleus supports CREB phosphorylation in hippocampal neurons. Nature 1998, 392:198-202.
33. Demjaha A., Maccabe J.H., Murray R.M. How genes and environmental factors determine the different neurodevelopmental trajectories of schizophrenia and bipolar disorder. Schizophrenia Bulletin 2011, 38:209-214.
34. v1.2 protein. Journal of Biological Chemistry 2011, 286:31557-31564.
35. Dolmetsch R.E., Pajvani U., Fife K., Spotts J.M., Greenberg M.E. Signaling to the nucleus by an L-type calcium channel-calmodulin complex through the MAP kinase pathway. Science 2001, 294:333-339.
36. Dolphin A.C. Calcium channel diversity: multiple roles of calcium channel subunits. Current Opinion in Neurobiology 2009, 19:237-244.
37. Dubovsky S.L., Buzan R., Thomas M., Kassner C., Cullum C.M. Nicardipine improves the antidepressant action of ECT but does not improve cognition. Journal of ECT 2001, 17:3-10.
38. Dubovsky S.L., Christiano J., Daniell L.C., Franks R.D., Murphy J., Adler L., Baker N., Harris R.A. Increased platelet intracellular calcium concentration in patients with bipolar affective disorders. Archives of General Psychiatry 1989, 46:632-638.
39. Dudkin S.M., Polev P.V., Soldatov N.M. Calcium entry blockers and oxiracetam have opposite effects on the density of dihydropyridine receptors in rat cerebral cortex. Brain Research 1990, 525:319-321.
40. Emamghoreishi M., Schlichter L., Li P.P., Parikh S., Sen J., Kamble A., Warsh J.J. High intracellular calcium concentrations in transformed lymphoblasts from subjects with bipolar I disorder. American Journal of Psychiatry 1997, 154:976-982.
41. Erk S., Meyer-Lindenberg A., Schnell K., Opitz von Boberfeld C., Esslinger C., Kirsch P., Grimm O., Arnold C., Haddad L., Witt S.H., Cichon S., Nothen M.M., Rietschel M., Walter H. Brain function in carriers of a genome-wide supported bipolar disorder variant. Archives of General Psychiatry 2010, 67:803-811.
42. 1 subunit of intestinal smooth muscle and other tissues. European Journal of Biochemistry 1994, 222:195-202.
43. Ferreira M.A., O'Donovan M.C., Meng Y.A., Jones I.R., Ruderfer D.M., Jones L., Fan J., Kirov G., Perlis R.H., Green E.K., Smoller J.W., Grozeva D., Stone J., Nikolov I., Chambert K., Hamshere M.L., Nimgaonkar V.L., Moskvina V., Thase M.E., Caesar S., Sachs G.S., Franklin J., Gordon-Smith K., Ardlie K.G., Gabriel S.B., Fraser C., Blumenstiel B., Defelice M., Breen G., Gill M., Morris D.W., Elkin A., Muir W.J., McGhee K.A., Williamson R., MacIntyre D.J., MacLean A.W., St C.D., Robinson M., Van Beck M., Pereira A.C., Kandaswamy R., McQuillin A., Collier D.A., Bass N.J., Young A.H., Lawrence J., Ferrier I.N., Anjorin A., Farmer A., Curtis D., Scolnick E.M., McGuffin P., Daly M.J., Corvin A.P., Holmans P.A., Blackwood D.H., Gurling H.M., Owen M.J., Purcell S.M., Sklar P., Craddock N. Collaborative genome-wide association analysis supports a role for ANK3 and CACNA1C in bipolar disorder. Nature Genetics 2008, 40:1056-1058.
44. 2+ channels after cocaine withdrawal. Synapse 2009, 63:690-697.
45. 2+ channels mediate expression of presynaptic LTP in amygdala. Nature Neuroscience 2009, 12:1093-1095.
46. Franke B., Vasquez A.A., Veltman J.A., Brunner H.G., Rijpkema M., Fernandez G. Genetic variation in CACNA1C, a gene associated with bipolar disorder, influences brainstem rather than gray matter volume in healthy individuals. Biological Psychiatry 2010, 68:586-588.
47. Ghosh A., Carnahan J., Greenberg M.E. Requirement for BDNF in activity-dependent survival of cortical neurons. Science 1994, 263:1618-1623.
48. 2+ channel signaling underlies long-term psychostimulant-induced behavioral and molecular plasticity. Journal of Neuroscience 2010, 30:17051-17062.
49. Gottesman I.I., Laursen T.M., Bertelsen A., Mortensen P.B. Severe mental disorders in offspring with 2 psychiatrically ill parents. Archives of General Psychiatry 2010, 67:252-257.
50. Gottesman I.I., Gould T.D. The endophenotype concept in psychiatry: etymology and strategic intentions. American Journal of Psychiatry 2003, 160:636-645.
51. Green E.K., Grozeva D., Jones I., Jones L., Kirov G., Caesar S., Gordon-Smith K., Fraser C., Forty L., Russell E., Hamshere M.L., Moskvina V., Nikolov I., Farmer A., McGuffin P., Holmans P.A., Owen M.J., O'Donovan M.C., Craddock N. The bipolar disorder risk allele at CACNA1C also confers risk of recurrent major depression and of schizophrenia. Molecular Psychiatry 2010, 15:1016-1022.
52. 2+ channels by calmodulin. Science STKE 2005, 2005:re15.
53. Hamshere M.L., Walters J.T., Smith R., Richards A.L., Green E., Grozeva D., Jones I., Forty L., Jones L., Gordon-Smith K., Riley B., O'Neill T., Kendler K.S., Sklar P., Purcell S., Kranz J., Morris D., Gill M., Holmans P., Craddock N., Corvin A., Owen M.J., O'Donovan M.C. Genome-wide significant associations in schizophrenia to ITIH3/4 CACNA1C and SDCCAG8, and extensive replication of associations reported by the Schizophrenia PGC. Molecular Psychiatry 2012.
54. Hill W.G. Estimation of linkage disequilibrium in randomly mating populations. Heredity (Edinb) 1974, 33:229-239.
55. 2+ channel diversity. Annual Review of Neuroscience 1994, 17:399-418.
56. 2+ signals for facilitation. Journal of Cell Biology 2005, 171:537-547.
57. Insel T., Cuthbert B., Garvey M., Heinssen R., Pine D.S., Quinn K., Sanislow C., Wang P. Research domain criteria (RDoC): toward a new classification framework for research on mental disorders. American Journal of Psychiatry 2010, 167:748-751.
58. Insel T.R., Cuthbert B.N. Endophenotypes: bridging genomic complexity and disorder heterogeneity. Biological Psychiatry 2009, 66:988-989.
59. Insel T.R., Scolnick E.M. Cure therapeutics and strategic prevention: raising the bar for mental health research. Molecular Psychiatry 2006, 11:11-17.
60. 2+ channels in ACC. Nature Neuroscience 2010, 13:482-488.
61. Jiang M., Swann J.W. A role for L-type calcium channels in the maturation of parvalbumin-containing hippocampal interneurons. Neuroscience 2005, 135:839-850.
62. Jogia J., Ruberto G., Lelli-Chiesa G., Vassos E., Maierú M., Tatarelli R., Girardi P., Collier D., Frangou S. The impact of the CACNA1C gene polymorphism on frontolimbic function in bipolar disorder. Molecular Psychiatry 2011.
63. Johnson A.D., Zhang Y., Papp A.C., Pinsonneault J.K., Lim J.E., Saffen D., Dai Z., Wang D., Sadee W. Polymorphisms affecting gene transcription and mRNA processing in pharmacogenetic candidate genes: detection through allelic expression imbalance in human target tissues. Pharmacogenetics Genomics 2008, 18:781-791.
64. Juckel G., Sass L., Heinz A. Anhedonia, self-experience in schizophrenia, and implications for treatment. Pharmacopsychiatry 2003, 36(Suppl 3):S176-S180.
65. Kaplan N.M. Calcium entry blockers in the treatment of hypertension. Current status and future prospects. Journal of the American Medical Association 1989, 262:817-823.
66. Keers R., Farmer A.E., Aitchison K.J. Extracting a needle from a haystack: reanalysis of whole genome data reveals a readily translatable finding. Psychological Medicine 2009, 39:1231-1235.
67. Kempton M.J., Ruberto G., Vassos E., Tatarelli R., Girardi P., Collier D., Frangou S. Effects of the CACNA1C risk allele for bipolar disorder on cerebral gray matter volume in healthy individuals. American Journal of Psychiatry 2009, 166:1413-1414.
68. Kendler K.S., Prescott C.A. A population-based twin study of lifetime major depression in men and women. Archives of General Psychiatry 1999, 56:39-44.
69. Kieseppä T., Partonen T., Haukka J., Kaprio J., Lönnqvist J. High concordance of bipolar I disorder in a nationwide sample of twins. American Journal of Psychiatry 2004, 161:1814-1821.
70. v1.3 L-type calcium channel with ryanodine receptor type 2 in the rat hippocampus. Journal of Biological Chemistry 2007, 282:32877-32889.
71. Kobrinsky E., Duong S.Q., Sheydina A., Soldatov N.M. Microdomain organization and frequency-dependence of CREB-dependent transcriptional signaling in heart cells. The FASEB Journal 2011, 25:1544-1555.
72. Kolarow R., Brigadski T., Lessmann V. Postsynaptic secretion of BDNF and NT-3 from hippocampal neurons depends on calcium calmodulin kinase II signaling and proceeds via delayed fusion pore opening. Journal of Neuroscience 2007, 27:10350-10364.
73. Krishnan V., Nestler E.J. Linking molecules to mood: new insight into the biology of depression. American Journal of Psychiatry 2010, 167:1305-1320.
74. Krug A., Nieratschker V., Markov V., Krach S., Jansen A., Zerres K., Eggermann T., Stocker T., Shah N.J., Treutlein J., Muhleisen T.W., Kircher T. Effect of CACNA1C rs1006737 on neural correlates of verbal fluency in healthy individuals. Neuroimage 2010, 49:1831-1836.
75. Lacinova L., Moosmang S., Langwieser N., Hofmann F., Kleppisch T. Cav1.2 calcium channels modulate the spiking pattern of hippocampal pyramidal cells. Life Science 2008, 82:41-49.
76. Langwieser N., Christel C.J., Kleppisch T., Hofmann F., Wotjak C.T., Moosmang S. Homeostatic switch in hebbian plasticity and fear learning after sustained loss of Cav1.2 calcium channels. Journal of Neuroscience 2010, 30:8367-8375.
77. 2+ channel activity. The FASEB Journal 2010, 24:5024-5032.
78. Lee A.S., Ra S., Rajadhyaksha A.M., Britt J.K., De Jesus-Cortes H., Gonzales K.L., Lee A., Moosmang S., Hofmann F., Pieper A.A., Rajadhyaksha A.M. Forebrain elimination of cacna1c mediates anxiety-like behavior in mice. Molecular Psychiatry 2012, [Epub ahead of print].
79. Leitch B., Szostek A., Lin R., Shevtsova O. Subcellular distribution of L-type calcium channel subtypes in rat hippocampal neurons. Neuroscience 2009, 164:641-657.
80. Lett T.A., Zai C.C., Tiwari A.K., Shaikh S.A., Likhodi O., Kennedy J.L., Muller D.J. ANK3, CACNA1C and ZNF804A gene variants in bipolar disorders and psychosis subphenotype. World Journal of Biological Psychiatry 2011, 12:392-397.
81. Levy N.A., Janicak P.G. Calcium channel antagonists for the treatment of bipolar disorder. Bipolar Disorders 2000, 2:108-119.
82. Lewontin R.C. The interaction of selection and linkage I. General considerations; heterotic models. Genetics 1964, 49:49-67.
83. Lewontin R.C. On measures of gametic disequilibrium. Genetics 1988, 120:849-852.
84. v1.2 calcium channel splice variant underlies hyperpolarized window current and enhanced state-dependent inhibition by nifedipine. Journal of Biological Chemistry 2007, 282:35133-35142.
85. Licata S.C., Freeman A.Y., Pierce-Bancroft A.F., Pierce R.C. Repeated stimulation of L-type calcium channels in the rat ventral tegmental area mimics the initiation of behavioral sensitization to cocaine. Psychopharmacology (Berl) 2000, 152:110-118.
86. Lichtenstein P., Yip B.H., Bjork C., Pawitan Y., Cannon T.D., Sullivan P.F., Hultman C.M. Common genetic determinants of schizophrenia and bipolar disorder in Swedish families: a population-based study. Lancet 2009, 373:234-239.
87. Liljelund P., Netzeband J.G., Gruol D.L. L-Type calcium channels mediate calcium oscillations in early postnatal Purkinje neurons. Journal of Neuroscience 2000, 20:7394-7403.
88. Lisman J.E., Coyle J.T., Green R.W., Javitt D.C., Benes F.M., Heckers S., Grace A.A. Circuit-based framework for understanding neurotransmitter and risk gene interactions in schizophrenia. Trends on Neurosciences 2008, 31:234-242.
89. Liu Y., Blackwood D.H., Caesar S., de Geus E.J., Farmer A., Ferreira M.A., Ferrier I.N., Fraser C., Gordon-Smith K., Green E.K., Grozeva D., Gurling H.M., Hamshere M.L., Heutink P., Holmans P.A., Hoogendijk W.J., Hottenga J.J., Jones L., Jones I.R., Kirov G., Lin D., McGuffin P., Moskvina V., Nolen W.A., Perlis R.H., Posthuma D., Scolnick E.M., Smit A.B., Smit J.H., Smoller J.W., St Clair D., van Dyck R., Verhage M., Willemsen G., Young A.H., Zandbelt T., Boomsma D.I., Craddock N., O'Donovan M.C., Owen M.J., Penninx B.W., Purcell S., Sklar P., Sullivan P.F. Meta-analysis of genome-wide association data of bipolar disorder and major depressive disorder. Molecular Psychiatry 2011, 16:2-4.
90. Maier W. Common risk genes for affective and schizophrenic psychoses. European Archives of Psychiatry and Clinical Neuroscience 2008, 258(Suppl 2):37-40.
91. Mallinger A.G., Thase M.E., Haskett R., Buttenfield J., Luckenbaugh D.A., Frank E., Kupfer D.J., Manji H.K. Verapamil augmentation of lithium treatment improves outcome in mania unresponsive to lithium alone: preliminary findings and a discussion of therapeutic mechanisms. Bipolar Disorder 2008, 10:856-866.
92. McGuffin P., Katz R., Watkins S., Rutherford J. A hospital-based twin register of the heritability of DSM-IV unipolar depression. Archives of General Psychiatry 1996, 53:129-136.
93. McGuffin P., Rijsdijk F., Andrew M., Sham P., Katz R., Cardno A. The heritability of bipolar affective disorder and the genetic relationship to unipolar depression. Archives of General Psychiatry 2003, 60:497-502.
94. Meyer-Lindenberg A., Weinberger D.R. Intermediate phenotypes and genetic mechanisms of psychiatric disorders. Nature Reviews Neuroscience 2006, 7:818-827.
95. Mikami A., Imoto K., Tanabe T., Niidome T., Mori Y., Takeshima H., Narumiya S., Numa S. Primary structure and functional expression of the cardiac dihydropyridine-sensitive calcium channel. Nature 1989, 340:230-233.
96. Mills K., Ansah T.A., Ali S.F., Mukherjee S., Shockley D.C. Augmented behavioral response and enhanced synaptosomal calcium transport induced by repeated cocaine administration are decreased by calcium channel blockers. Life Science 2007, 81:600-608.
97. Mogilnicka E., Czyrak A., Maj J. Dihydropyridine calcium channel antagonists reduce immobility in the mouse behavioral despair test; antidepressants facilitate nifedipine action. European Journal of Pharmacology 1987, 138:413-416.
98. 2+ channels in NMDA receptor-independent synaptic plasticity and spatial memory. Journal of Neuroscience 2005, 25:9883-9892.
99. Moskvina V., Craddock N., Holmans P., Nikolov I., Pahwa J.S., Green E., Owen M.J., O'Donovan M.C. Gene-wide analyses of genome-wide association data sets: evidence for multiple common risk alleles for schizophrenia and bipolar disorder and for overlap in genetic risk. Molecular Psychiatry 2009, 14:252-260.
100. Narayanan D., Xi Q., Pfeffer L.M., Jaggar J.H. Mitochondria control functional CaV1.2 expression in smooth muscle cells of cerebral arteries. Circulation Research 2010, 107:631-641.
101. Nestler E.J., Carlezon W.A. The mesolimbic dopamine reward circuit in depression. Biological Psychiatry 2006, 59:1151-1159.
102. 2+ channels in the induction of long-term potentiation in the basolateral amygdala-dentate gyrus pathway of anesthetized rats. Brain Research 2004, 1017:218-221.
103. Nyegaard M., Demontis D., Foldager L., Hedemand A., Flint T.J., Sorensen K.M., Andersen P.S., Nordentoft M., Werge T., Pedersen C.B., Hougaard D.M., Mortensen P.B., Mors O., Borglum A.D. CACNA1C (rs1006737) is associated with schizophrenia. Molecular Psychiatry 2010, 15:119-121.
104. V1.2) to synaptic and extrasynaptic compartments in hippocampal neurons. European Journal of Neuroscience 2004, 19:2109-2122.
105. 2+ elevating to depressing. Journal of Neuroscience 1995, 15:5065-5077.
106. 2+ channels on excessive dopamine release from rat caudate putamen. Physiology & Behavior 2000, 68:641-649.
107. v1.2 (L-type) calcium channels. Journal of Biological Chemistry 2011, 286:13945-13953.
108. v1.2 isoforms under the control of distinct 5' flanking regulatory elements. FEBS Letters 2003, 546:349-354.
109. Pazzaglia P.J., Post R.M., Ketter T.A., Callahan A.M., Marangell L.B., Frye M.A., George M.S., Kimbrell T.A., Leverich G.S., Cora-Locatelli G., Luckenbaugh D. Nimodipine monotherapy and carbamazepine augmentation in patients with refractory recurrent affective illness. Journal of Clinical Psychopharmacology 1998, 18:404-413.
110. Pe'er I., Yelensky R., Altshuler D., Daly M.J. Estimation of the multiple testing burden for genomewide association studies of nearly all common variants. Genetic Epidemiology 2008, 32:381-385.
111. Perez-Reyes E., Wei X., Castellano A., Birnbaumer L. Molecular diversity of L-type calcium channels Evidence for alternative splicing of the transcripts of three non-allelic genes. Journal of Biological Chemistry 1990, 265:20430-20436.
112. Perez-Reyes E., Wei X.Y., Castellano A., Birnbaumer L. Molecular diversity of L-type calcium channels Evidence for alternative splicing of the transcripts of three non-allelic genes. Journal of Biological Chemistry 1990, 265:20430-20436.
113. Perova T., Wasserman M.J., Li P.P., Warsh J.J. Hyperactive intracellular calcium dynamics in B lymphoblasts from patients with bipolar I disorder. International Journal of Neuropsychopharmacology 2008, 11:185-196.
114. Perrier E., Pompei F., Ruberto G., Vassos E., Collier D., Frangou S. Initial evidence for the role of CACNA1C on subcortical brain morphology in patients with bipolar disorder. European Psychiatry 2011, 26:135-137.
115. 2+ channels and dependent on age, sex, and brain region. Neuroscience 2003, 116:995-1003.
116. Perrot-Sinal T.S., Davis A.M., Gregerson K.A., Kao J.P., McCarthy M.M. Estradiol enhances excitatory gamma-aminobutyric [corrected] acid-mediated calcium signaling in neonatal hypothalamic neurons. Endocrinology 2001, 142:2238-2243.
117. Pierce R.C., Kumaresan V. The mesolimbic dopamine system: the final common pathway for the reinforcing effect of drugs of abuse?. Neuroscience & Biobehavioral Reviews 2006, 30:215-238.
118. 2+ channel (CCHL1A1) to chromosome 12p12-pter. Genomics 1991, 10:835-839.
119. Pucilowski O., Plaznik A., Overstreet D.H. Isradipine suppresses amphetamine-induced conditioned place preference and locomotor stimulation in the rat. Neuropsychopharmacology 1995, 12:239-244.
120. Quinn E.M., Hill M., Anney R., Gill M., Corvin A.P., Morris D.W. Evidence for cis-acting regulation of ANK3 and CACNA1C gene expression. Bipolar Disorder 2010, 12:440-445.
121. Radua J., Surguladze S.A., Marshall N., Walshe M., Bramon E., Collier D.A., Prata D.P., Murray R.M., McDonald C. The impact of CACNA1C allelic variation on effective connectivity during emotional processing in bipolar disorder. Molecular Psychiatry 2012.
122. 2+ channels mediate adaptation of extracellular signal-regulated kinase 1/2 phosphorylation in the ventral tegmental area after chronic amphetamine treatment. Journal of Neuroscience 2004, 24:7464-7476.
123. Reich D.E., Cargill M., Bolk S., Ireland J., Sabeti P.C., Richter D.J., Lavery T., Kouyoumjian R., Farhadian S.F., Ward R., Lander E.S. Linkage disequilibrium in the human genome. Nature 2001, 411:199-204.
124. Ripke S., Sanders A.R., Kendler K.S., Levinson D.F., Sklar P., Holmans P.A., Lin D.Y., Duan J., Ophoff R.A., Andreassen O.A., Scolnick E., Cichon S., St Clair D., Corvin A., Gurling H., Werge T., Rujescu D., Blackwood D.H., Pato C.N., Malhotra A.K., Purcell S., Dudbridge F., Neale B.M., Rossin L., Visscher P.M., Posthuma D., Ruderfer D.M., Fanous A., Stefansson H., Steinberg S., Mowry B.J., Golimbet V., De Hert M., Jonsson E.G., Bitter I., Pietilainen O.P., Collier D.A., Tosato S., Agartz I., Albus M., Alexander M., Amdur R.L., Amin F., Bass N., Bergen S.E., Black D.W., Borglum A.D., Brown M.A., Bruggeman R., Buccola N.G., Byerley W.F., Cahn W., Cantor R.M., Carr V.J., Catts S.V., Choudhury K., Cloninger C.R., Cormican P., Craddock N., Danoy P.A., Datta S., de Haan L., Demontis D., Dikeos D., Djurovic S., Donnelly P., Donohoe G., Duong L., Dwyer S., Fink-Jensen A., Freedman R., Freimer N.B., Friedl M., Georgieva L., Giegling I., Gill M., Glenthoj B., Godard S., Hamshere M., Hansen M., Hansen T., Hartmann A.M., Henskens F.A., Hougaard D.M., Hultman C.M., Ingason A., Jablensky A.V., Jakobsen K.D., Jay M., Jurgens G., Kahn R.S., Keller M.C., Kenis G., Kenny E., Kim Y., Kirov G.K., Konnerth H., Konte B., Krabbendam L., Krasucki R., Lasseter V.K., Laurent C., Lawrence J., Lencz T., Lerer F.B., Liang K.Y., Lichtenstein P., Lieberman J.A., Linszen D.H., Lonnqvist J., Loughland C.M., Maclean A.W., Maher B.S., Maier W., Mallet J., Malloy P., Mattheisen M., Mattingsdal M., McGhee K.A., McGrath J.J., McIntosh A., McLean D.E., McQuillin A., Melle I., Michie P.T., Milanova V., Morris D.W., Mors O., Mortensen P.B., Moskvina V., Muglia P., Myin-Germeys I., Nertney D.A., Nestadt G., Nielsen J., Nikolov I., Nordentoft M., Norton N., Nothen M.M., O'Dushlaine C.T., Olincy A., Olsen L., O'Neill F.A., Orntoft T.F., Owen M.J., Pantelis C., Papadimitriou G., Pato M.T., Peltonen L., Petursson H., Pickard B., Pimm J., Pulver A.E., Puri V., Quested D., Quinn E.M., Rasmussen H.B., Rethelyi J.M., Ribble R., Rietschel M., Riley B.P., Ruggeri M., Schall U., Schulze T.G., Schwab S.G., Scott R.J., Shi J., Sigurdsson E., Silverman J.M., Spencer C.C., Stefansson K., Strange A., Strengman E., Stroup T.S., Suvisaari J., Terenius L., Thirumalai S., Thygesen J.H., Timm S., Toncheva D., van den Oord E., van Os J., van Winkel R., Veldink J., Walsh D., Wang A.G., Wiersma D., Wildenauer D.B., Williams H.J., Williams N.M., Wormley B., Zammit S., Sullivan P.F., O'Donovan M.C., Daly M.J., Gejman P.V. Genome-wide association study identifies five new schizophrenia loci. Nature Genetics 2011, 43:969-976.
125. Rose E.J., Donohoe G. Brain vs behavior: an effect size comparison of neuroimaging and cognitive studies of genetic risk for schizophrenia. Schizophrenia Bulletin 2012.
126. Roussos P., Giakoumaki S.G., Georgakopoulos A., Robakis N.K., Bitsios P. The CACNA1C and ANK3 risk alleles impact on affective personality traits and startle reactivity but not on cognition or gating in healthy males. Bipolar Disorder 2011, 13:250-259.
127. Sandler V.M., Barbara J.-G. Calcium-induced calcium release contributes to action potential-evoked calcium transients in hippocampal CA1 pyramidal neurons. Journal of Neuroscience 1999, 19:4325-4336.
128. 2+ channels. Proceedings of the National Academy of Sciences USA 2008, 105:15148-15153.
129. v1.3 channels. Journal of Neuroscience 2011, 31:13562-13575.
130. 1 subunit of the L-type voltage-dependent calcium channel from normal human heart. Proceedings of the National Academy of Sciences USA 1993, 90:6228-6232.
131. v1.2) calcium channel gene in the mouse. Journal of Biological Chemistry 2000, 275:39193-39199.
132. 2+ channel. Journal of Biological Chemistry 2002, 277:6813-6821.
133. Shi J., Potash J.B., Knowles J.A., Weissman M.M., Coryell W., Scheftner W.A., Lawson W.B., DePaulo J.R., Gejman P.V., Sanders A.R., Johnson J.K., Adams P., Chaudhury S., Jancic D., Evgrafov O., Zvinyatskovskiy A., Ertman N., Gladis M., Neimanas K., Goodell M., Hale N., Ney N., Verma R., Mirel D., Holmans P., Levinson D.F. Genome-wide association study of recurrent early-onset major depressive disorder. Molecular Psychiatry 2011, 16:193-201.
134. v1 channels in the development of psychological dependence. Synapse 2010, 64:440-444.
135. Shinnick-Gallagher P., McKernan M.G., Xie J., Zinebi F. L-type voltage-gated calcium channels are involved in the in vivo and in vitro expression of fear conditioning. Annals of the New York Academy of Sciences 2003, 985:135-149.
136. 2+ channels. Journal of Clinical Investigation 2004, 113:1430-1439.
137. Sinnegger-Brauns M.J., Huber I.G., Koschak A., Wild C., Obermair G.J., Einzinger U., Hoda J.C., Sartori S.B., Striessnig J. Expression and 1,4-dihydropyridine-binding properties of brain L-type calcium channel isoforms. Molecular Pharmacology 2009, 75:407-414.
138. Sklar P., Gabriel S.B., McInnis M.G., Bennett P., Lim Y.M., Tsan G., Schaffner S., Kirov G., Jones I., Owen M., Craddock N., DePaulo J.R., Lander E.S. Family-based association study of 76 candidate genes in bipolar disorder: BDNF is a potential risk locus. Brain-derived neutrophic factor. Molecular Psychiatry 2002, 7:579-593.
139. Sklar P., Ripke S., Scott L.J., Andreassen O.A., Cichon S., Craddock N., Edenberg H.J., Nurnberger J.I., Rietschel M., Blackwood D., Corvin A., Flickinger M., Guan W., Mattingsdal M., McQuillin A., Kwan P., Wienker T.F., Daly M., Dudbridge F., Holmans P.A., Lin D., Burmeister M., Greenwood T.A., Hamshere M.L., Muglia P., Smith E.N., Zandi P.P., Nievergelt C.M., McKinney R., Shilling P.D., Schork N.J., Bloss C.S., Foroud T., Koller D.L., Gershon E.S., Liu C., Badner J.A., Scheftner W.A., Lawson W.B., Nwulia E.A., Hipolito M., Coryell W., Rice J., Byerley W., McMahon F.J., Schulze T.G., Berrettini W., Lohoff F.W., Potash J.B., Mahon P.B., McInnis M.G., Zollner S., Zhang P., Craig D.W., Szelinger S., Barrett T.B., Breuer R., Meier S., Strohmaier J., Witt S.H., Tozzi F., Farmer A., McGuffin P., Strauss J., Xu W., Kennedy J.L., Vincent J.B., Matthews K., Day R., Ferreira M.A., O'Dushlaine C., Perlis R., Raychaudhuri S., Ruderfer D., Hyoun P.L., Smoller J.W., Li J., Absher D., Thompson R.C., Meng F.G., Schatzberg A.F., Bunney W.E., Barchas J.D., Jones E.G., Watson S.J., Myers R.M., Akil H., Boehnke M., Chambert K., Moran J., Scolnick E., Djurovic S., Melle I., Morken G., Gill M., Morris D., Quinn E., Muhleisen T.W., Degenhardt F.A., Mattheisen M., Schumacher J., Maier W., Steffens M., Propping P., Nothen M.M., Anjorin A., Bass N., Gurling H., Kandaswamy R., Lawrence J., McGhee K., McIntosh A., McLean A.W., Muir W.J., Pickard B.S., Breen G., St Clair D., Caesar S., Gordon-Smith K., Jones L., Fraser C., Green E.K., Grozeva D., Jones I.R., Kirov G., Moskvina V., Nikolov I., O'Donovan M.C., Owen M.J., Collier D.A., Elkin A., Williamson R., Young A.H., Ferrier I.N., Stefansson K., Stefansson H., Thornorgeirsson T., Steinberg S., Gustafsson O., Bergen S.E., Nimgaonkar V., Hultman C., Landen M., Lichtenstein P., Sullivan P., Schalling M., Osby U., Backlund L., Frisen L., Langstrom N., Jamain S., Leboyer M., Etain B., Bellivier F., Petursson H., Sigur Sson E., Muller-Mysok B., Lucae S., Schwarz M., Schofield P.R., Martin N., Montgomery G.W., Lathrop M., Oskarsson H., Bauer M., Wright A., Mitchell P.B., Hautzinger M., Reif A., Kelsoe J.R., Purcell S.M. Large-scale genome-wide association analysis of bipolar disorder identifies a new susceptibility locus near ODZ4. Nature Genetics 2011, 43:977-983.
140. Sklar P., Smoller J.W., Fan J., Ferreira M.A.R., Perlis R.H., Chambert K., Nimgaonkar V.L., McQueen M.B., Faraone S.V., Kirby A., de Bakker P.I.W., Ogdie M.N., Thase M.E., Sachs G.S., Todd-Brown K., Gabriel S.B., Sougnez C., Gates C., Blumenstiel B., Defelice M., Ardlie K.G., Franklin J., Muir W.J., McGhee K.A., MacIntyre D.J., McLean A., VanBeck M., McQuillin A., Bass N.J., Robinson M., Lawrence J., Anjorin A., Curtis D., Scolnick E.M., Daly M.J., Blackwood D.H., Gurling H.M., Purcell S.M. Whole-genome association study of bipolar disorder. Molecular Psychiatry 2008, 13:558-569.
141. Slatkin M. Linkage disequilibrium--understanding the evolutionary past and mapping the medical future. Nature Reviews Genetics 2008, 9:477-485.
142. Small S.A., Schobel S.A., Buxton R.B., Witter M.P., Barnes C.A. A pathophysiological framework of hippocampal dysfunction in ageing and disease. Nature Reviews Neuroscience 2011, 12:585-601.
143. Soeiro-de-Souza M.G., Otaduy M.C., Dias C.Z., Bio D.S., Machado-Vieira R., Moreno R.A. The impact of the CACNA1C risk allele on limbic structures and facial emotions recognition in bipolar disorder subjects and healthy controls. Journal of Affective Disorders 2012.
144. 2+ channel transcripts in human fibroblasts. Proceedings of the National Academy of Sciences USA 1992, 89:4628-4632.
145. 2+ channel. Genomics 1994, 22:77-87.
146. Schwartz P.J., Timothy K.W., Decher N., Kumar P., Sachse F.B., Beggs A.H., Sanguinetti M.C., Keating M.T. Severe arrhythmia disorder caused by cardiac L-type calcium channel mutations. Proceedings of the National Academy of Sciences USA 2005, 102:8089-8096. (discussion 8086-8088).
147. v1.2 calcium channel dysfunction causes a multisystem disorder including arrhythmia and autism. Cell 2004, 119:19-31.
148. Strohmaier J., Amelang M., Hothorn L.A., Witt S.H., Nieratschker V., Gerhard D., Meier S., Wüst S., Frank J., Loerbroks A., Rietschel M., Stürmer T., Schulze T.G. The psychiatric vulnerability gene CACNA1C and its sex-specific relationship with personality traits, resilience factors and depressive symptoms in the general population. Mol Psychiatry 2012, [Epub ahead of print].
149. Subramanian J., Morozov A. Erk1/2 inhibit synaptic vesicle exocytosis through L-type calcium channels. Journal of Neuroscience 2011, 31:4755-4764.
150. Sullivan P.F., de Geus E.J., Willemsen G., James M.R., Smit J.H., Zandbelt T., Arolt V., Baune B.T., Blackwood D., Cichon S., Coventry W.L., Domschke K., Farmer A., Fava M., Gordon S.D., He Q., Heath A.C., Heutink P., Holsboer F., Hoogendijk W.J., Hottenga J.J., Hu Y., Kohli M., Lin D., Lucae S., Macintyre D.J., Maier W., McGhee K.A., McGuffin P., Montgomery G.W., Muir W.J., Nolen W.A., Nothen M.M., Perlis R.H., Pirlo K., Posthuma D., Rietschel M., Rizzu P., Schosser A., Smit A.B., Smoller J.W., Tzeng J.Y., van Dyck R., Verhage M., Zitman F.G., Martin N.G., Wray N.R., Boomsma D.I., Penninx B.W. Genome-wide association for major depressive disorder: a possible role for the presynaptic protein piccolo. Molecular Psychiatry 2009, 14:359-375.
151. Suzuki A., Josselyn S.A., Frankland P.W., Masushige S., Silva A.J., Kida S. Memory reconsolidation and extinction have distinct temporal and biochemical signatures. Journal of Neuroscience 2004, 24:4787-4795.
152. 2+ channels. Journal of Biological Chemistry 2000, 275:17269-17275.
153. Tanabe T., Takeshima H., Mikami A., Flockerzi V., Takahashi H., Kangawa K., Kojima M., Matsuo H., Hirose T., Numa S. Primary structure of the receptor for calcium channel blockers from skeletal muscle. Nature 1987, 328:313-318.
154. v1. 2 alpha1 subunit. Journal of Biological Chemistry 2004, 279:44335-44343.
155. v1.2 L-type calcium channel splicing by Fox proteins. Molecular and Cellular Biology 2009, 29:4757-4765.
156. Taragano F.E., Allegri R., Vicario A., Bagnatti P., Lyketsos C.G. A double blind, randomized clinical trial assessing the efficacy and safety of augmenting standard antidepressant therapy with nimodipine in the treatment of 'vascular depression'. International Journal Of Geriatric Psychiatry 2001, 16:254-260.
157. Taragano F.E., Bagnatti P., Allegri R.F. A double-blind, randomized clinical trial to assess the augmentation with nimodipine of antidepressant therapy in the treatment of vascular depression. International Psychogeriatric 2005, 17:487-498.
158. Thimm M., Kircher T., Kellermann T., Markov V., Krach S., Jansen A., Zerres K., Eggermann T., Stocker T., Shah N.J., Nothen M.M., Rietschel M., Witt S.H., Mathiak K., Krug A. Effects of a CACNA1C genotype on attention networks in healthy individuals. Psychological Medicine 2011, 41:1551-1561.
159. 1C subunit. PNAS 2006, 103:17024-17029.
160. Triggle D. Biochemical and pharmacologic difference among calcium channel antagonists: clinical implications. Calcium Antagonists in Clinical Medicine 1992, 1-27. Hanley & Belfus, Philadelphia. M. Epstein (Ed.).
161. Viveros M.P., Martin S., Ormazabal M.J., Alfaro M.J., Martin M.I. Effects of nimodipine and nifedipine upon behavior and regional brain monoamines in the rat. Psychopharmacology (Berl) 1996, 127:123-132.
162. Wang D., Papp A.C., Binkley P.F., Johnson J.A., Sadee W. Highly variable mRNA expression and splicing of L-type voltage-dependent calcium channel α subunit 1C in human heart tissues. Pharmacogenetics Genomics 2006, 16:735-745.
163. Wang F., McIntosh A.M., He Y., Gelernter J., Blumberg H.P. The association of genetic variation in CACNA1C with structure and function of a frontotemporal system. Bipolar Disorder 2011, 13:696-700.
164. Weick J.P., Groth R.D., Isaksen A.L., Mermelstein P.G. Interactions with PDZ proteins are required for L-type calcium channels to activate cAMP response element-binding protein-dependent gene expression. Journal of Neuroscience 2003, 23:3446-3456.
165. Wessa M., Linke J., Witt S.H., Nieratschker V., Esslinger C., Kirsch P., Grimm O., Hennerici M.G., Gass A., King A.V., Rietschel M. The CACNA1C risk variant for bipolar disorder influences limbic activity. Molecular Psychiatry 2010, 15:1126-1127.
166. West A.E., Chen W.G., Dalva M.B., Dolmetsch R.E., Kornhauser J.M., Shaywitz A.J., Takasu M.A., Tao X., Greenberg M.E. Calcium regulation of neuronal gene expression. Proceedings of the National Academy of Sciences USA 2001, 98:11024-11031.
167. Wheeler D.G., Barrett C.F., Groth R.D., Safa P., Tsien R.W. CaMKII locally encodes L-type channel activity to signal to nuclear CREB in excitation-transcription coupling. Journal of Cell Biology 2008, 183:849-863.
168. v1.2 disrupts remote spatial memories in mice. Learning & Memory 2008, 15:1-5.
169. Williams H.J., Craddock N., Russo G., Hamshere M.L., Moskvina V., Dwyer S., Smith R.L., Green E., Grozeva D., Holmans P., Owen M.J., O'Donovan M.C. Most genome-wide significant susceptibility loci for schizophrenia and bipolar disorder reported to date cross-traditional diagnostic boundaries. Human Molecular Genetics 2011, 20:387-391.
170. Yan H., Yuan W., Velculescu V.E., Vogelstein B., Kinzler K.W. Allelic variation in human gene expression. Science 2002, 297:1143.
171. v1.2 L-type calcium channel levels and function to influence GABAergic short-term plasticity. Journal of Neuroscience 2009, 29:15660-15668.
172. Yoshii M., Watabe S. Enhancement of neuronal calcium channel currents by the nootropic agent, nefiracetam (DM-9384), in NG108-15 cells. Brain Research 1994, 642:123-131.
173. Zhang Q., Shen Q., Xu Z., Chen M., Cheng L., Zhai J., Gu H., Bao X., Chen X., Wang K., Deng X., Ji F., Liu C., Li J., Dong Q., Chen C. The effects of CACNA1C gene polymorphism on spatial working memory in both healthy controls and patients with schizophrenia or bipolar disorder. Neuropsychopharmacology 2011.
174. 2+ channels. Journal of Neuroscience 2004, 24:4698-4708.
175. Zuccotti A., Clementi S., Reinbothe T., Torrente A., Vandael D.H., Pirone A. Structural and functional differences between L-type calcium channels: crucial issues for future selective targeting. Trends in Pharmacological Sciences 2011, 32:366-375.
176. Zuhlke R.D., Pitt G.S., Deisseroth K., Tsien R.W., Reuter H. Calmodulin supports both inactivation and facilitation of L-type calcium channels. Nature 1999, 399:159-162.